Lucas Castro Mendez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lucas Castro Mendez has a total of 359 co-authors. Here are the top co-authors by number of shared publications:
- Adam G. Sowalsky
Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, USA
17 shared publications - Alan Pollack
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, FL
17 shared publications - Anand B. Desai
12Summa Health System – Akron Campus, Akron, Ohio
17 shared publications - Anson T. Ku
Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA
17 shared publications - Baris Turkbey
Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
17 shared publications - Boon Hao Hong
National Cancer Centre Singapore 1 , Singapore, Singapore
17 shared publications
Latest Publications
- 26 September 2026
- Published by Elsevier in Brachytherapy
- Vol. 25 (6) , 973-980
High-dose-rate prostate brachytherapy imaging optimization: A motorized sagittal three-dimensional ultrasound acquisition system
- 26 September 2026
- Published by Elsevier in Brachytherapy
- Vol. 25 (6) , 973-980
High-dose-rate prostate brachytherapy imaging optimization: A motorized sagittal three-dimensional ultrasound acquisition system
- Open Access
- 15 September 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 224
Two-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial
- 15 September 2026
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 224
Open AccessTwo-year outcomes following PSMA PET and MRI guided prostate SABR with simultaneous focal boost: a brief report from the ARGOS-CLIMBER phase 1/2 trial
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Representativeness of study participants
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Representativeness of study participants
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Patient characteristics of the NCCS EBRT cohort
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Patient characteristics of the NCCS EBRT cohort
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Patient characteristics of the combined RTOG 9202, 9413, and 9902 cohorts
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Patient characteristics of the combined RTOG 9202, 9413, and 9902 cohorts
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Associations between MRI tumor volumes and transcriptional signatures
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Associations between MRI tumor volumes and transcriptional signatures
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Multivariable analysis tables of the combined RTOG 9202, 9413, and 9902 cohorts
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Multivariable analysis tables of the combined RTOG 9202, 9413, and 9902 cohorts
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Gene list of a prostate cancer-specific TGF-β activity signature
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Gene list of a prostate cancer-specific TGF-β activity signature
- Open Access
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Radiomic features of radiation response
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence
Radiomic features of radiation response